HGF not only activates the c-MET signaling pathway to induce EGFR-TKIs resistance in lung adenocarcinomas [23, 29], but it also promotes the transcription of the endogenous c-MET gene [30]. The gene discussed is HGF; the disease is lung adenocarcinoma.